Sou Hu Cai Jing·2025-06-19 16:42Group 1 - The core viewpoint of the news is the recent performance and structure of the China Europe Medical Health Mixed A fund, which has seen a decline in value and has a significant portion of its holdings in individual investors [1][4] - As of June 19, the fund's net value is 1.65 yuan, with a cumulative decline of 8.01% over the last five trading days [1] - The fund was established in September 2016, with a total scale of 15.613 billion yuan and a cumulative return of 82.22% since inception [1] Group 2 - The current fund manager, Ms. Ge Lan, has a background in biomedical engineering and has held various positions in research and fund management since joining China Europe Fund Management in 2014 [2] - Ms. Ge has managed multiple funds, including the China Europe Medical Health Mixed Fund since September 2016 [2] Group 3 - As of March 31, 2025, the top ten holdings of the China Europe Medical Health Mixed A fund account for a total of 55.30%, with significant investments in companies such as Heng Rui Pharmaceutical (10.60%) and WuXi AppTec (9.95%) [3]